Inovio starts dosing in Phase II trial of DNA vaccine for MERS
The trial, being carried out in Jordan and Lebanon, is intended to support the company in developing the first MERS vaccine.
News
Blood thinner benefits moderately ill Covid-19 patients in study
In critically ill patients, a full dose of heparin reduced major thrombotic events but did...
Business optimism improves for the second straight month in July: Poll
Business and consumer confidence improved in July backed by increase in consumer spending and hiring.
FDA lifts partial clinical hold on Novartis’ SMA drug programme
Based on safety concerns in a pre-clinical study of IT OAV-101, the FDA placed a...
ClinTex introduces blockchain-driven application for clinical trials
The application performs data analysis to provide intuitive operational insights that can enable efficiency in...
University of Leeds to assess cannabis-based drug for brain tumours
A Phase II trial will test the addition of Sativex to chemotherapy for improving survival in recurrent glioblastoma patients.
CytoDyn receives Brazilian ANVISA’s approval for Phase III Covid-19 trial
The trial will have 612 hospitalised Covid-19 patients who need oxygen support enrolled at up to 35 centres in Brazil.
Lilly-Incyte’s baricitinib reduces mortality in Phase III Covid-19 trial
In the second quarter of 2021, Lilly’s Covid-19 antibodies fetched $148.9m in global revenue.
Arcturus to initiate trial of Covid-19 vaccine in Vietnam
The Phase I/II/III trial will enrol up to 21,000 adults to evaluate the safety, immunogenicity and efficacy of the mRNA vaccine.
Servier’s Tibsovo improves survival in Phase III AML trial
The treatment met the primary and all key secondary goals, with a safety profile comparable to prior findings.
UK trial explores Covid-19 vaccine dose interval for pregnant women
The trial will involve the vaccination of more than 600 pregnant women with Pfizer-BioNTech or Moderna Covid-19 jabs.
